Brandtree

Who owns Amneal?

Amneal is owned by Amneal Pharmaceuticals, Inc. (the United States, NASDAQ: AMRX).[1]

Evidence: Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27, SEC EDGAR, 27 February 2026. Verified from filings; last checked .

Key facts

Current owner
Amneal Pharmaceuticals, Inc. verified
Owner HQ
🇺🇸 United States, Bridgewater
Origin
🇺🇸 United States
Category
Healthcare & pharma › Drug makers › Generics & biosimilars
Parent ticker
NASDAQ: AMRX
Last verified
· 1 sources

About Amneal

Amneal is the name on the generic, injectable and biosimilar medicines in the Affordable Medicines segment of Amneal Pharmaceuticals. The 10-K for 2025 says the segment serves group purchasing organisations, wholesalers and large retail chains, and that Amneal products sold by AvKARE are reported inside it.

Ownership timeline of Amneal

  1. Current owner Amneal [1] verified

Where Amneal sits in Amneal

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Amneal sits in Amneal Tree of 6 brands under Amneal. Amneal Amneal AvKARE 65.1% AvPAK 65.1% Brekiya Crexont Rytary

Open the full Amneal ownership tree →

See the full Amneal brand portfolio (6) →

Other brands owned by Amneal

Amneal controls 6 brands on Brandtree, 6 of them in healthcare & pharma.

Also in healthcare & pharma

All Amneal brands →

Other brands in drug makers, and who owns them

The 24 brands in drug makers on Brandtree belong to 6 owners. The largest is Gilead, with 5; Amneal has 4.

BrandOwnerOwner based in
Descovy Gilead 🇺🇸 United States
Bemfola Richter 🇭🇺 Hungary
Ajovy Teva 🇮🇱 Israel
Celebrex Viatris 🇺🇸 United States
Habitrol Dr. Reddy's 🇮🇳 India
Sunlenca Gilead 🇺🇸 United States
Trodelvy Gilead 🇺🇸 United States
Yescarta Gilead 🇺🇸 United States

Every brand in drug makers and its owner →

About the owner: Amneal

Amneal is a publicly listed company headquartered in Bridgewater, United States. Brandtree records 6 brands under its control, and it is listed as NASDAQ: AMRX.

Amneal Pharmaceuticals is a Bridgewater, New Jersey drugmaker whose 10-K for 2025 describes three segments: Affordable Medicines (generics, injectables and biosimilars), Specialty (branded products for central nervous system and endocrine disorders) and AvKARE, a pharmaceutical distributor. It had over 8,500 employees at 31 December 2025 and operates in the United States, India and Ireland.

Amneal: full profile, brands and acquisition history →

🇺🇸 Amneal and other American brands

Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Amneal is not one of them.

All American brands and who owns them →

Frequently asked questions

Who is the parent company of Amneal?

The parent company of Amneal is Amneal Pharmaceuticals, Inc., a publicly listed company headquartered in the United States.

Is Amneal American?

Yes. Amneal originated in the United States and its owner, Amneal Pharmaceuticals, Inc., is also headquartered in the United States.

Is Amneal still owned by Amneal Pharmaceuticals, Inc.?

Yes. As of 14 October 2026, Amneal is still owned by Amneal Pharmaceuticals, Inc. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 14 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.